Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 6, 2011, Pages

  Rastaldo, Raffaella ^a,b   Cappello, Sandra ^a,b   Folino, Anna ^a   Berta, Giovanni N ^a,b   Sprio, Andrea E ^a   Losano, Gianni ^a   Samaja, Michele ^b,c   Pagliaro, Pasquale ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Italian Institute for Cardiovascular Research INRC   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

APJ receptor; Ischemia Reperfusion; Myocardial protection; Preconditioning

Indexed keywords

APELIN 13; APELIN RECEPTOR; CARDIOVASCULAR AGENT; LACTATE DEHYDROGENASE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ENZYME RELEASE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958049167     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01177.2010     Document Type: Article

References (52)

1. Arnaud C, Laubriet A, Joyeux M, Godin-Ribuot D, Rochette L, Demenge P, Ribuot C. Role of nitric oxide synthases in the infarct size-reducing effect conferred by heat stress in isolated rat hearts. Br J Pharmacol 132: 1845-1851, 2001.
2. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ, Woo YJ. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110: II187-II193, 2004.
3. Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo Corti A R, Losano G, Cerra MC. Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Am J Physiol Heart Circ Physiol 293: H719-H727, 2007.
4. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 145: 287-294, 2008.
5. Cohen MV, Yang XM, Downey JM. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol Heart Circ Physiol 277: H1754-H1761, 1999.
6. Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I, Yacoub MH, Terracciano CM. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357: 889-895, 2007.
7. Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, Toscano JP. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47: 13150-13152, 2008.
8. Gelpi RJ, Morales C, Cohen MV, Downey JM. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97: 40-46, 2002.
9. Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70: 212-221, 2006.
10. Hashimoto T, Kihara M, Ishida J, Imai N, Yoshida S, Toya Y, Fukamizu A, Kitamura H, Umemura S. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26: 1267-1272, 2006.
11. Hausenloy DJ, Baxter G, Bell R, Bøtker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 105: 677-686, 2010.
12. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116: 173-191, 2007.
13. Hearse DJ. The elusive coypu: the importance of collateral flow and the search for an alternative to the dog. Cardiovasc Res 45: 215-219, 2000.
14. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N, Okunishi H, Kihara M, Umemura S, Sugiyama F, Yagami K, Kasuya Y, Mochizuki N, Fukamizu A. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279: 26274-26279, 2004.
15. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston Sharma S NR, Neilson I, Webb DJ, Megson IL, Flapan AD, Newby DE. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 52: 908-913, 2008.
16. Jenkins DP, Pugsley WB, Yellon DM. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol 27: 1623-1632, 1995.
17. Jin ZQ, Karliner JS, Vessey DA. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res 79: 134-140, 2008.
18. Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132: 1255-1260, 2001.
19. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 23: 162-171, 2001.
20. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 146: 271-277, 2008.
21. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118: 119-125, 2004.
22. Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localization of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126: 233-240, 2005.
23. Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J, Nakagawa M. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 98: 319-428, 2003.
24. Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer Fisher PW YA, Wittkamp M, Hawkins J, Chou E, Kukreja AK, Wang X, Marwaha VR, Xi L. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Vascul Pharmacol 42: 219- 232, 2005.
25. Lee DK, Cheng R, Nguyen T, Fan T, Karyawasam AP, Liu Osmond DH Y, George SR, O'Dowd BF. Characterization of apelin, the ligand for APJ receptor. J Neurochem 74: 34-41, 2000.
26. Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98: 337-346, 2003.
27. Lu XH, Ran K, Xu JM, Chang YT. Preconditioning of morphine protects rabbit myocardium from ischemia-reperfusion injury. Zhejiang Da Xue Xue Bao Yi Xue Ban 38: 399-403, 2009.
28. Massion PB, Pelat M, Belge C, Balligand JL. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 142: 144-150, 2005.
29. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737-746, 1987.
30. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy Shi X JL, Petronis A, George SR, Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136: 355-360, 1993.
31. Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34: 33-43, 2003.
32. Penna C, Mancardi D, Tullio F, Pagliaro P. Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection. J Surg Res 153: 231-238, 2009.
33. Penna C, Tullio F, Merlino A, Moro F, Raimondo S, Rastaldo R, Perrelli MG, Mancardi D, Pagliaro P. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol 104: 390-402, 2009.
34. Piper HM, Abdallah Y, Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61: 365-371, 2004.
35. Rastaldo R, Cappello S, Folino A, Di Stilo A, Chegaev K, Tritto I, Pagliaro P, Losano G. Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts. J Physiol Pharmacol 61: 21-27, 2010.
36. Rastaldo R, Cappello S, Folino A, Losano G. Effect of Apelin-APJ system in postischaemic myocardial protection: a pharmacological postconditioning tool? Antioxid Redox Signal 14: 909-922, 2011.
37. Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, Losano G. Nitric oxide and cardiac function. Life Sci 81: 779-793, 2007.
38. Sadigh B, Shahgaldi K, Sylvén C, Quintana M, Winter R. Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve. Coron Artery Dis 20: 354-359, 2009.
39. Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42: 453-458, 2007.
40. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia- reperfusion injury. Basic Res Cardiol 102: 518-528, 2007.
41. Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB, Yellon DM. Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin. Cardiovasc Drugs Ther 21: 409- 414, 2007.
42. Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola Pikkarainen S H, Piuhola J, Rysä J, Tóth M, Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91: 434-440, 2002.
43. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou Kawamata Y MX, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471-476, 1998.
44. Vessey DA, Li L, Kelley M, Zhang J, Karliner JS. Sphingosine can preand post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. J Biochem 22: 113-118, 2008.
45. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning - A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100: 295-310, 2005.
46. Wang C, Jun-Feng D, Feng W, Hai-Chang W. Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes. Am J Physiol Heart Circ Physiol 294: H2540-H2546, 2008.
47. Weselcouch EO, Baird AJ, Sleph PG, Dzwonczyk S, Murray HN, Grover GJ. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 29: 126-132, 1995.
48. Yoon MH, Kim WM, Lee HG, Kim YO, Huang LJ, An TH. Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats. Neurosci Lett 441: 125-128, 2008.
49. Zang WJ, Sun L, Yu XJ. Cardioprotection of ischemic postconditioning and pharmacological post-treatment with adenosine or acetylcholine. Sheng Li Xue Bao 59: 593-600, 2007.
50. Zeng XJ, Zhang LK, Wag HX, Lu LQ, Ma LQ, Tang CS. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30: 1144-1152, 2009.
51. Zhou L, Burnett AL, Huang PL, Becker LC, Kuppusamy P, Kass DA, Kevin Donahue J, Proud D, Sham JS, Dawson TM, Xu KY. Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. Biochem Biophys Res Commun 294: 1030-1035, 2002.
52. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404-1407, 1987.